Laboratory response to anthrax bioterrorism, New York City, 2001

Emerging Infectious Diseases

Volumn 8, Issue 10, 2002, Pages 1096-1102

  Heller, Michael B ^a   Bunning, Michel L ^b   France, Martin E B ^a   Niemeyer, Debra M ^a   Peruski, Leonard ^a,c   Naimi, Tim ^c   Talboy, Phillip M ^b   Murray, Patrick H ^b   Pietz, Harald W ^c   Kornblum, John ^d   Oleszko, William ^e   Beatrice, Sara T ^f  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c The Joint Staff   (United States)

^d Joint Program Executive Office for Chemical and Biological Defense   (United States)

^e NAVAL MEDICAL RESEARCH CENTER   (United States)

^f Seymour Johnson Air Force Base   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR SAMPLING; ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; BIOSAFETY; ENVIRONMENTAL RELEASE; HUMAN; LABORATORY; MEDICAL STAFF; QUALITY CONTROL; UNITED STATES;

EID: 0036774191     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0810.020376     Document Type: Article

References (13)

1. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon: Medical and public health Management. JAMA 1999;281:1735-45.
2. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-19.
3. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997;278:399-411.
4. Richmond JY, McKinney RW, editors. Biosafety in microbiological and biomedical laboratories. HHS pub. no. CDC 93-8395, 3rd edition. Washington: U.S. Department of Health and Human Services Public Health Service, Centers for Disease Control and Prevention and National Institutes of Health; 1993.
5. Centers for Disease Control and Prevention. Public Health Emergency Preparedness and Response: Agents of Bioterrorism. CDC:PHEPR 2002. Available from: URL: http://www.bt.cdc.gov/labissues/index.asp
6. Underwood A, Springen K. Newsweek: Anthrax: A spreading scare: The medical facts. PR Newswire 2001 Oct 14. Available from: URL: http://www.findarticles.com
7. New York City Public Health Laboratories. Draft Bioterrorism Response Laboratory Protocols. New York: New York City Department of Health; 2002.
8. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yoken RH. Manual of Clinical Microbiology. 7th Edition. Washington: American Society for Microbiology; 1999.
9. New York City Department of Health. Exposure Control Plans. New York: Department of Health; 2001.
10. United States Code: Title 18, Section 2332(a): Added Pub. L. 103-322, Title VI, Section 60023(a) (Sept. 13, 1994, amended Oct. 21, 1998) Threatening to use a weapon of mass destruction against federal property.
11. Centers for Disease Control and Prevention. New York City Department of Health response to terrorist attack, September 11, 2001. MMWR Morb Mortal Wkly Rep 2001;50:821-2.
12. Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001;50:941-8.
13. Fine A, Layton M. Lessons from the West Nile viral encephalitis outbreak in New York City 1999: implications for bioterrorism preparedness. Clin Infect Dis 2001;32:277.